Serum neurofilament light chain and optical coherence tomography measures in MS
Open Access
- 18 May 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology Neuroimmunology & Neuroinflammation
Abstract
Objective To study the association between serum neurofilament light chain (sNfL) and multiple optical coherence tomography (OCT) measures in patients with MS and healthy controls (HCs). Methods In this prospective study, 110 patients with MS were recruited, together with 52 age- and sex-matched HCs. Clinical evaluation and spectral domain OCT and sNfL were obtained at baseline and after 5.5 years of follow-up. Nested linear mixed models were used to assess differences between MS vs HC and associations between sNfL and OCT measures. Partial correlation coefficients are reported, and p values were adjusted for the false discovery rate. Results At baseline, peripapillary retinal nerve fiber layer thickness (pRNFLT) and macular ganglion cell and inner plexiform layer thickness (mGCIP) were significantly lower in MS than HC both in MS-associated optic neuritis (MSON) (p = 0.007, p = 0.001) and nonaffected MSON (n-MSON) eyes (p = 0.003, p = 0.018), along with total macular volume (TMV) in n-MSON eyes (p = 0.011). At follow-up, MS showed significantly lower pRNFLT, mGCIP, and TMV both in MSON and n-MSON eyes (p < 0.001) compared with HC. In MS n-MSON eyes, sNfL was significantly associated with baseline pRNFLT and mGCIP (q = 0.019). No significant associations were found in MSON eyes. Conclusions This study confirms the ability of sNfL to detect neurodegeneration in MS and advocates for the inclusion of sNfL and OCT measures in clinical trials. Classification of evidence This study provides Class III evidence that sNfL levels were associated with MS neurodegeneration measured by OCT.Keywords
This publication has 48 references indexed in Scilit:
- Association between pathological and MRI findings in multiple sclerosisThe Lancet Neurology, 2019
- Optical coherence tomography as a means to characterize visual pathway involvement in multiple sclerosisCurrent Opinion in Neurology, 2018
- Gray matter atrophy patterns in multiple sclerosis: A 10-year source-based morphometry studyNeuroImage: Clinical, 2017
- Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysisThe Lancet Neurology, 2017
- Optical coherence tomography: A quantitative tool to measure neurodegeneration and facilitate testing of novel treatments for tissue protection in multiple sclerosisJournal of Neuroimmunology, 2017
- Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routineExpert Review of Neurotherapeutics, 2016
- Optical coherence tomography and neurodegeneration: are eyes the windows to the brain?Expert Review of Neurotherapeutics, 2016
- Gray matter damage predicts the accumulation of disability 13 years later in MSNeurology, 2013
- Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypesNeurology, 2010
- Grey matter pathology in multiple sclerosisThe Lancet Neurology, 2008